CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice
Vipul K. Singh(Houston Methodist), Arshad Khan(King Fahd University of Petroleum and Minerals)
Cited by 15
Related Papers
NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice
|Frontiers in Immunology|2020|25